"Jacksoneye Lake Villa IL offers such vision correction procedures as Bladefree LASIK, PRK, advanced options in cataract lens replacement including laser guided cataract surgery, contact lens implants, corneal transplants, and specialized glaucoma treatment. We are a Certified Dry Eye Center featuring Lipiflow. We tailor your vision correction plan with a help of a series of diagnostic tests and expertise. Jacksoneye clinic is specialized in LASIK eye surgery, corneal diseases, cataract treatment and cosmetic procedures."

During the past decade, Jackson Eye conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 5 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jackson Eye" #1 sponsor was "Innovative Medical" with 4 trials, followed by "Shire" with 3 trials sponsored, "Kala Pharmaceuticals, Inc." with 2 trials sponsored, "TearScience, Inc." with 2 trials sponsored and "Allergan" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jackson Eye" #1 collaborator was "AbbVie" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Jackson Eye" are "Dry Eye" (3 trials), "Blepharitis" (2 trials), "Dry Eye Disease" (2 trials), "Dry Eye Syndromes" (2 trials) and "Meibomian Gland Dysfunction" (2 trials). Many other conditions were trialed in "Jackson Eye" in a lesser frequency.

Most popular intervention types in "Jackson Eye" are "Drug" (12 trials), "Device" (6 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PVP-I 0.6%" (2 trials), "SHP640" (2 trials), "0.5% Omaveloxolone Ophthalmic Suspension" (1 trials) and "1% Omaveloxolone Ophthalmic Suspension" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jackson Eye" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Jackson Eye". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Jackson Eye, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jackson Eye, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".